ACRX
AcelRx Pharmaceuticals, Inc
stock NASDAQ

I wouldn’t.
An organic derivative can be simulated chemically once Achieves spends in proof of concept and licensing.
IP protection takes years and millions to pursue and many copy cats tend to be in and out fast specially in the nicotine market. Look at Juul, they took the hit and the copycats are still pumping… seems it’s a new disposable vape brand coming out every week.
Sadly biotech is a hard sell… I learned from ACRX and their subfetanyl drugs and applicators. Went to a conference and they pulled my heart strings with their presentation. So now I look into the practicality of drug itself…
Would price point and research be enough for insurance companies to pay for in lieu of having members smoking? Or would the collective percentage of patients with cancer or other diseases out weight the cost.
Not sure if it all makes sense it’s 3am and trying to get back to sleep! Lol 😂

I wouldn’t.
An organic derivative can be simulated chemically once Achieves spends in proof of concept and licensing.
IP protection takes years and millions to pursue and many copy cats tend to be in and out fast specially in the nicotine market. Look at Juul, they took the hit and the copycats are still pumping… seems it’s a new disposable vape brand coming out every week.
Sadly biotech is a hard sell… I learned from ACRX and their subfetanyl drugs and applicators. Went to a conference and they pulled my heart strings with their presentation. So now I look into the practicality of drug itself…
Would price point and research be enough for insurance companies to pay for in lieu of having members smoking? Or would the collective percentage of patients with cancer or other diseases out weight the cost.
Not sure if it all makes sense it’s 3am and trying to get back to sleep! Lol 😂